These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35474231)

  • 1. Role of gut microbiota in the immunopathology of atherosclerosis: Focus on immune cells.
    Wang C; Deng H; Liu F; Yin Q; Xia L
    Scand J Immunol; 2022 Jul; 96(1):e13174. PubMed ID: 35474231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiota-artery axis: A bridge between dietary lipids and atherosclerosis?
    Zhang Q; Zhang L; Chen C; Li P; Lu B
    Prog Lipid Res; 2023 Jan; 89():101209. PubMed ID: 36473673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Polyphenols on Atherosclerosis Development.
    Ziółkiewicz A; Kasprzak-Drozd K; Rusinek R; Markut-Miotła E; Oniszczuk A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota.
    Zhao X; Oduro PK; Tong W; Wang Y; Gao X; Wang Q
    Pharmacol Res; 2021 Jan; 163():105362. PubMed ID: 33285231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis.
    Vourakis M; Mayer G; Rousseau G
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics, gut microbiome, and cardiovascular diseases: An update.
    Dosh L; Ghazi M; Haddad K; El Masri J; Hawi J; Leone A; Basset C; Geagea AG; Jurjus R; Jurjus A
    Transpl Immunol; 2024 Apr; 83():102000. PubMed ID: 38262540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.
    Duttaroy AK
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33401598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the mechanism underlying the anti-diabetic effect of dietary component: a focus on gut microbiota.
    Zhao Y; Li M; Wang Y; Geng R; Fang J; Liu Q; Kang SG; Zeng WC; Huang K; Tong T
    Crit Rev Food Sci Nutr; 2023; 63(25):7378-7398. PubMed ID: 35243943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between gut microbiome and cardiovascular disease.
    Peng J; Xiao X; Hu M; Zhang X
    Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis.
    Yeh CF; Chen YH; Liu SF; Kao HL; Wu MS; Yang KC; Wu WK
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases.
    Di Meo F; Donato S; Di Pardo A; Maglione V; Filosa S; Crispi S
    Curr Drug Metab; 2018; 19(6):478-489. PubMed ID: 29623833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota and Its Metabolites in Atherosclerosis Development.
    Pieczynska MD; Yang Y; Petrykowski S; Horbanczuk OK; Atanasov AG; Horbanczuk JO
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut microbiome and cardiovascular disease: current knowledge and clinical potential.
    Ahmad AF; Dwivedi G; O'Gara F; Caparros-Martin J; Ward NC
    Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H923-H938. PubMed ID: 31469291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
    Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
    Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota and Atherosclerosis.
    Li DY; Tang WHW
    Curr Atheroscler Rep; 2017 Aug; 19(10):39. PubMed ID: 28842845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel insights in the relationship of gut microbiota and coronary artery diseases.
    Ramírez-Macías I; Orenes-Piñero E; Camelo-Castillo A; Rivera-Caravaca JM; López-García C; Marín F
    Crit Rev Food Sci Nutr; 2022; 62(14):3738-3750. PubMed ID: 33399007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.
    Zhu Y; Li Q; Jiang H
    APMIS; 2020 May; 128(5):353-366. PubMed ID: 32108960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of probiotics and prebiotics with the gut microbiota.
    Ballan R; Battistini C; Xavier-Santos D; Saad SMI
    Prog Mol Biol Transl Sci; 2020; 171():265-300. PubMed ID: 32475525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.